Impaired Hippo signaling promotes Rho1-JNK-dependent growth.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25583514.
- Also identified by DOI 10.1073/pnas.1415020112 and PMC identifier 4313816.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Hippo and c-Jun N-terminal kinase (JNK) pathway both regulate growth and contribute to tumorigenesis when dysregulated. Whereas the Hippo pathway acts via the transcription coactivator Yki/YAP to regulate target gene expression, JNK signaling, triggered by various modulators including Rho GTPases, activates the transcription factors Jun and Fos. Here, we show that impaired Hippo signaling induces JNK activation through Rho1. Blocking Rho1-JNK signaling suppresses Yki-induced overgrowth in the wing disk, whereas ectopic Rho1 expression promotes tissue growth when apoptosis is prohibited. Furthermore, Yki directly regulates Rho1 transcription via the transcription factor Sd. Thus, our results have identified a novel molecular link between the Hippo and JNK pathways and implicated the essential role of the JNK pathway in Hippo signaling-related tumorigenesis.
Medical subject headings
- Drosophila Proteins
- Imaginal Discs
- Intracellular Signaling Peptides and Proteins
- JNK Mitogen-Activated Protein Kinases
- MAP Kinase Signaling System
- Protein Serine-Threonine Kinases
- Wings, Animal
- rho GTP-Binding Proteins